Current status of biologics in severe asthma management

Further understanding is needed on how and when to switch from one biological therapy to another
There is still no consensus on the appropriate length of waiting time before a patient is classified as a non-responder
The efficacy of biologics in severe asthma has been demonstrated in a number of trials in recent years, but further research is needed to understand the long-term effects of biological therapy
Several clinical studies have demonstrated the oral corticosteroid-sparing effect of biologics